Nordic 5-Fluorouracil/Leucovorin Bolus Schedule Combined with Oxaliplatin (Nordic FLOX) as First-line Treatment of Metastatic Colorectal Cancer

By Sørbye Halfdan   Dahl Olav  

Acta Oncologica, Vol. 42, Iss. 8, 2003-12 ,pp. : 827-831

Informa Healthcare

Access to resources Recommend Favorite

XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study

By Rosati Gerardo   Avallone Antonio   Aprile Giuseppe   Butera Alfredo   Reggiardo Giorgio   Bilancia Domenico  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 257-264

Springer Publishing Company

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of capecitabine plus oxaliplatin (XELOX): A new first-line option in metastatic colorectal cancer

By Makatsoris Thomas   Kalofonos Haralabos   Aravantinos Gerasimos   Papadimitriou Christos   Kastritis Efstathios   Rigatos Sotirios   Xiros Nikolaos   Petsas Theodore   Economopoulos Theofanis   Sakadamis Athanassios   Fountzilas George  

International Journal of Gastrointestinal Cancer, Vol. 35, Iss. 2, 2005-04 ,pp. : 103-109

Humana Press, Inc

Access to resources Recommend Favorite

Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer

By Hori Natsuko  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 435-438

Springer Publishing Company

Access to resources Recommend Favorite